Skip to content

XLK vs SMH: returns, risk and drawdowns compared

Technology Select Sector SPDR Fund against VanEck Semiconductor ETF, over the same 19 years (December 2006 to October 2026) with dividends reinvested.

Data updated October 2026

XLK

Technology Select Sector SPDR Fund

10,000 became

87,249

A year on average
+11.5%
Annual volatility
22.0%
Deepest fall
−50.5%
Worst month
−45.0%

SMH

VanEck Semiconductor ETF

10,000 became

468,690

A year on average
+21.3%
Annual volatility
26.0%
Deepest fall
−52.0%
Worst month
−19.5%

SMH came out ahead by 9.8 percentage points a year from December 2006 to October 2026. SMH swung more (26.0% against 22.0% a year). The correlation of monthly returns was 0.72: they usually moved together.

Growth of 10,000: XLK vs SMH

0200k400k200720142021
XLK — Technology Select Sector SPDR FundSMH — VanEck Semiconductor ETF

Who was ahead, and when

The gap between the two over the previous three years, at each month-end. Above zero XLK had returned more, below zero SMH. XLK was ahead in 13% of the 204 three-year periods.

−50 pt−25 pt0200720142021

Annualised 3-year return of XLK minus that of SMH, in percentage points a year.

Falls from the previous high

-40%-20%0%200720142021
XLKSMH

Month-end values. Deepest fall: XLK −50.5%, SMH −52.0%.

All the figures

XLKSMH
Annual return (CAGR)+11.5%+21.3%
Total return+772%+4587%
Annual volatility22.0%26.0%
Deepest fall (month-end)−50.5%−52.0%
Worst month−45.0%−19.5%
Best month+20.0%+32.2%
Positive months62%64%
Best year2023: +55.4%2023: +73.4%
Worst year2008: −41.9%2008: −44.8%
1-year return+18.9%+57.8%
5 years, a year+1.2%+33.2%
10 years, a year+14.7%+33.0%
Trading currencyUSDUSD

First nine rows: the same 239 months for both funds. Trailing returns: to each fund’s last close.

Year by year

2025
XLK−37.8%
SMH+49.2%
2024
XLK+21.2%
SMH+39.1%
2023
XLK+55.4%
SMH+73.4%
2022
XLK−28.1%
SMH−33.9%
2021
XLK+34.2%
SMH+41.8%
2020
XLK+42.7%
SMH+55.0%
2019
XLK+48.9%
SMH+63.2%
2018
XLK−2.4%
SMH−9.0%
2017
XLK+33.2%
SMH+38.5%
2016
XLK+14.0%
SMH+35.5%
2015
XLK+4.5%
SMH−0.3%
2014
XLK+16.8%
SMH+30.2%
2013
XLK+25.1%
SMH+33.3%
2012
XLK+14.3%
SMH+10.2%
2011
XLK+1.8%
SMH+0.9%
2010
XLK+10.6%
SMH+18.8%
2009
XLK+50.1%
SMH+63.4%
2008
XLK−41.9%
SMH−44.8%
2007
XLK+15.0%
SMH+5.7%

Full calendar years both funds were trading. The higher of the two each year is in bold.

Holding both: half XLK, half SMH

XLK aloneSMH alone50/50
A year on average+11.5%+21.3%+16.9%
Annual volatility22.0%26.0%22.2%
Deepest fall (month-end)−50.5%−52.0%−50.2%
Worst month−45.0%−19.5%−16.0%

Because the two did not always move together, the mix swung less than the average of the two (22.2% against 24.0%). Rebalanced to 50/50 every month, before costs.

Questions

Which has returned more, XLK or SMH?

From December 2006 to October 2026, XLK returned +11.5% a year and SMH +21.3% a year, with dividends reinvested. Over rolling 3-year periods XLK did better in 13% of cases. Past returns do not predict future returns.

Which is riskier, XLK or SMH?

Over the same months annual volatility was 22.0% for XLK and 26.0% for SMH; the deepest fall from a month-end high was 50.5% and 52.0%, and the worst single month −45.0% and −19.5%.

How correlated are XLK and SMH?

The correlation of their monthly returns was 0.72: they usually moved together. Combining them has historically given some diversification.

What about holding both XLK and SMH?

Half in each, rebalanced every month, returned +16.9% a year over the same period, with 22.2% annual volatility and a deepest month-end fall of 50.2%.

More comparisons

How the figures are calculated

Total return in the fund’s trading currency, from end-of-day prices with dividends reinvested on the ex-date. The fund’s own ongoing charges are already reflected in its price; trading costs, taxes and currency conversion are not included. Past returns do not predict future returns.

The comparison uses only the months in which both funds have prices, so the figures cover the same period even when one fund is older.

Source: MarketStack end-of-day prices, total return with dividends reinvested. Figures are historical and descriptive; they are not forecasts and not investment advice. MEDGE Capital does not recommend buying or selling any instrument. Risk disclaimer.